CD8A and cancer: In a metastatic urothelial cancer cohort, patients’ response to anti-PD-L1 immunotherapy was positively correlated to CD8+ T-effector cell infiltration while negatively correlated to TGFβ signaling in cancer-related fibroblasts (19).